Quality-of-life among head and neck cancer survivors at one year after treatment – A systematic review
Introduction
The diagnosis of head and neck (H&N) cancer and associated treatment can have a disproportionately severe impact on patients’ quality-of-life (QoL). H&N cancers include those originating in the oral cavity, salivary glands, larynx, paranasal sinuses, nasal cavity and pharynx (nasopharynx, oropharynx or hypopharynx).1 In 2008, the age-adjusted incidence and mortality rates in the United States were 10.6 and 2.5 per 1,000,000 respectively, and both have been decreasing.2 With the improvement in cancer detection and intensive multi-model treatments, the prognosis of cancer survivors is relatively favourable, and the population of survivors is increasing.2 However, the side-effects of treatment cannot be underestimated.3
Treatments for H&N cancer include surgery, radiotherapy (RT), chemotherapy, targeted therapy or a combination of these modalities. However, these treatments often lead to undesirable consequences that have a marked effect on both physical and psychosocial aspects of the patient’s life.1 Quality-of-life is a broad concept, concerning an individual’s perceptions, physical and psychosocial state, personal beliefs and relationship to the environment.4 With the importance of QoL being recognised in recent years, it has been increasingly used as an outcome measure in cancer research. A recent review reported a number of potential determinants influencing QoL in patients with H&N cancer.5 However, the significance of the relationship between QoL and the potential determinants was not fully indicated. The factors were summarised regardless of their temporal relationship to the patient’s treatment, and their effects on short- or long-term QoL were not distinguished or discussed.
Patients with H&N cancer usually show a deterioration in global QoL scores immediately after treatment, but there is generally a return to baseline scores by one year after treatment.5, 6 Appropriate interventions are therefore important in improving patient status during this critical period. Quality-of-life at one year after treatment has been an important predictor of long-term survival5, 7, 8 and of QoL at 5 years.9 Understanding the relationships between QoL and potential determinants may assist with designing interventions aimed at improving QoL, and the purpose of this systematic review is thus to evaluate patient QoL status and to identify the determinants affecting it among H&N cancer survivors, at one year after the completion of treatment.
Section snippets
Search strategies
A comprehensive search of the literature was carried out in December 2011. Electronic databases – Pubmed, Medline, Scopus, Sciencedirect and CINAHL – were used to identify relevant studies published from 2000 to December 2011. Bearing in mind the rapid advances that have been made in the treatment of H&N cancer over the past decade, we have limited the inclusion of studies to those carried out since 2000. A combination of keywords – head and neck cancer, quality-of-life, health-related
Literature search results
A total of 4338 citations were identified through five databases. Of these, 1872 duplicates were removed, leaving 2466. Following a scan of the titles and abstracts, 80 potential studies were identified and after a detailed examination of the full texts, 39 were found to meet all inclusion criteria and were critically appraised. Two were further excluded because of their generally poor quality. Fig. 1 illustrates the search and the inclusion of studies. The scores for the methodological
Discussion
With recent advances in treatment and cancer care services, this review focuses on published studies investigating QoL in H&N cancer survivors over the past decade, and provides updated information on the QoL of this population, with 37 relatively high-quality studies involving over 4000 H&N cancer patients. Although previous research findings have suggested that QoL and treatment-related morbidities return to baseline after treatment in H&N cancer survivors,49 our review suggests that some
Conclusion
This review paper examines the QoL of patients one year after treatment, and seeks to identify the determinants affecting the QoL of H&N cancer survivors. While patients’ global QoL recovers by 12 months after treatment in this group, problems with physical functioning, fatigue, xerostomia and sticky saliva persist. Regular monitoring should be carried out to identify the presence of these potential outstanding problems. Various determinants of QoL at 12 months were identified, and further
Conflict of interest statement
None declared.
References (51)
- et al.
Enhancing epidemiologic research on head and neck cancer: INHANCE – The international head and neck cancer epidemiology consortium
Oral Oncol
(2009) - et al.
Prospective evaluation of quality of life after oncologic surgery for oral cancer
Int J Oral Maxillofac Surg
(2002) - et al.
Quality of life among long-term breast cancer survivors: a systematic review
Eur J Cancer
(2005) - et al.
Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy
Oral Oncol
(2001) - et al.
Matched case–control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report
Int J Radiat Oncol Biol Phys
(2005) - et al.
Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer
Int J Radiat Oncol Biol Phys
(2007) - et al.
Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study
Int J Radiat Oncol Biol.Phys
(2003) - et al.
Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer
Int J Radiat Oncol Biol Phys
(2011) - et al.
The effect of neck dissection on quality of life after chemoradiation
Otolaryngol Head Neck Surg
(2008) - et al.
Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial
Radiother Oncol
(2008)
Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer
Int J Radiat Oncol Biol Phys
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
Lancet Oncol
Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients
Cancer Detect Prev
Quality of life research in head and neck cancer: a review of the current state of the science
Crit Rev Oncol Hematol
The validity of the hospital anxiety and depression scale. An updated literature review
J Psychosom Res
Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome
Eur Arch Otorhinolaryngol
Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
Br J Cancer
Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation
Oncology
Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer
Head Neck
Quality of life and head and neck cancer: a 5 year prospective study
Laryngoscope
A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data
Laryngoscope
Free-flap head and neck reconstruction and quality of life: a 2-year prospective study
Laryngoscope
Cited by (120)
Quality of life assessment after microvascular head and neck reconstruction: a systematic review of available tools
2024, British Journal of Oral and Maxillofacial SurgeryDifferential use of postoperative psychosocial and physical services among older adults with head and neck cancer
2023, Journal of Geriatric OncologyWhat Risk Factors Are Associated With Poorer Quality of Life in Patients With Head and Neck Cancer?
2023, Journal of Oral and Maxillofacial SurgeryThe Tooth Hurts: Dental Health After Radiation Therapy for Head and Neck Cancer
2022, International Journal of Radiation Oncology Biology PhysicsPembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
2022, Oral OncologyCitation Excerpt :Patients with head and neck squamous cell carcinoma (HNSCC) are at high risk of poor health-related quality of life (HRQoL) [1]. The tumor itself or treatments such as surgical resection or chemoradiotherapy can cause facial disfigurement, damage to anatomic structures, and deterioration in physical functioning, which can compound common cancer symptoms of pain and fatigue, and result in diminished HRQoL [1–3]. For the past decade, the standard first-line treatment for unresectable HNSCC has been cetuximab plus platinum and 5-fluorouracil (5-FU) [4].